| 44.86 Data as of May 24 |  -0.04 / -0.09%Today’s Change | 43.16 Today|||52-Week Range 65.93 | -21.79% Year-to-Date |
| Previous close | 44.90 |
| Today’s open | 44.61 |
| Day’s range | 43.84 - 44.91 |
| Volume | 365,049 |
| Average volume (3 months) | 608,040 |
| Market cap | $1.4B |
| Dividend yield | -- |
| Earnings growth (last year) | +32.89% |
| Earnings growth (this year) | +8.55% |
| Earnings growth (next 5 years) | +15.80% |
| Revenue growth (last year) | +11.01% |
| P/E ratio | 21.6 |
| Price/Sales | 1.74 |
| Price/Book | 3.03 |
| Today’s change | Today’s % change | |
|---|---|---|
| ELGXEndologix Inc | -0.08 | -0.57% |
| RIGLRigel Pharmaceutical... | +0.07 | +1.51% |
| LFVNLifeVantage Corp | 0.00 | 0.00% |
| NATRNature's Sunshine Pr... | +0.08 | +0.52% |
| Next reporting date | July 25, 2013 |
| EPS forecast (this quarter) | $0.60 |
| Annual revenue (last year) | $950.9M |
| Annual profit (last year) | $60.8M |
| Net profit margin | 6.40% |
Sector Retail Trade |
Industry Drugstore Chains |
Chief Executive Officer & Director Anthony N. Truesdale, |
Chief Financial Officer & Executive Vice President Brenda M. Galgano, CPA |
Corporate headquarters North Bergen, New Jersey |
.
